资讯

Medpage Today on MSN1 个月
Treating Generalized Myasthenia Gravis
Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor (FcRn) ...
来自MSN9 个月
Argenx gets FDA approval for Vyvgart Hytrulo for CIDP (update)
The Dutch biotech company said the product was the first and only neonatal Fc receptor blocker approved to treat the condition. The product is co-formulated with Halozyme Therapeutics’ (HALO ...